3-Methylxanthine

3-Methylxanthine

SCHEMBL1892894

Cn1c(=O)[nH]c(=O)c2[nH]cnc21.Cn1c(=O)[nH]c2nc[nH]c2c1=O

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 9/20 0.77
ADORA2A P29274 8/20 0.77
ATAD2 Q6PL18 1/20 0.53
ADORA3 P0DMS8 8/20 0.52
PDE4A P27815 7/20 0.52
PDE4B Q07343 7/20 0.52
PDE4C Q08493 7/20 0.52
PDE4D Q08499 7/20 0.52
ADORA1 P30542 2/20 0.52
HPGD P15428 1/20 0.52
BLM P54132 1/20 0.52
PDE3A Q14432 1/20 0.52
HSD17B10 Q99714 1/20 0.52
PIK3CD O00329 1/20 0.51
ALPL P05186 1/20 0.51
TMIGD3 P0DMS9 1/20 0.51
CYP2C19 P33261 1/20 0.51
HIF1A Q16665 1/20 0.51
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1-Methylxanthine SCHEMBL10996 0.88 ADORA2B (1.00) ADORA2BADORA2AATAD2ADORA3PDE4A
3-Methylxanthine SCHEMBL237146 0.88 ADORA2A (0.64) ADORA2BADORA2AATAD2ADORA3PDE4A
1-Methylxanthine SCHEMBL27529726 0.86 ADORA2B (0.96) ADORA2BADORA2AATAD2ADORA3PDE4A
3-Methylxanthine SCHEMBL4020124 0.86 ADORA2A (0.62) ADORA2BADORA2AATAD2ADORA3PDE4A
3-Methylxanthine SCHEMBL30753411 0.86 ADORA2A (0.62) ADORA2BADORA2AATAD2ADORA3PDE4A
3-Methylxanthine SCHEMBL9317914 0.86 ADORA2A (0.62) ADORA2BADORA2AATAD2ADORA3PDE4A
1-Methylxanthine SCHEMBL9682658 0.86 ADORA2B (0.96) ADORA2BADORA2AATAD2ADORA3PDE4A
1-Methylxanthine SCHEMBL28309011 0.86 ADORA2B (0.96) ADORA2BADORA2AATAD2ADORA3PDE4A
Theophylline Anhydrous SCHEMBL1128138 0.86 ADORA2A (0.77) ADORA2BADORA2AATAD2ADORA3PDE4A
1-Methylxanthine SCHEMBL16859909 0.84 ADORA2B (0.79) ADORA2BADORA2AATAD2ADORA3PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180251854-A1 Method For Predicting Therapy Responsiveness In Basal Like Tumors WIRTZ RALPH MARKUS (DE) 2018-09-06 US disclosed
US-9932639-B2 Method for predicting therapy responsiveness in basal like tumors WIRTZ RALPH MARKUS (DE) 2018-04-03 US disclosed
CN-102264235-A Food product fortified with methylxanthines 2011-11-30 CN disclosed
EP-2369939-A2 FOOD PRODUCTS ENRICHED WITH METHYLXANTHINES Unilever PLC (GB) 2011-10-05 EP disclosed
US-20110118129-A1 METHOD FOR PREDICTING THERAPY RESPONSIVENESS IN BASAL LIKE TUMORS Wirtz, Ralph Markus (DE) 2011-05-19 US disclosed
EP-2215251-A2 METHOD FOR PREDICTING THERAPY RESPONSIVENESS IN BASAL LIKE TUMORS Siemens Healthcare Diagnostics GmbH (DE) 2010-08-11 EP disclosed
WO-2010076112-A2 FOOD PRODUCTS ENRICHED WITH METHYLXANTHINES UNILEVER PLC (GB) 2010-07-08 WO disclosed
WO-2009068423-A2 METHOD FOR PREDICTING THERAPY RESPONSIVENESS IN BASAL LIKE TUMORS SIEMENS HEALTHCARE DIAGNOSTICS GMBH (DE) 2009-06-04 WO disclosed